CyberKnife(M6) Treatment Cases

Patient: 10-year-old female
Diagnosis: Brain Malignant Tumor (Glioma)
Symptoms: Weakness in the legs, unclear speech
Treatment:Started CyberKnife radiotherapy on June 14, 2020
Radiation dose to P丁V: 25 Gy in 5 fractions (5 Gy per fraction)
Outcome:Follow-up imaging two months later showed a slight reduction in the brainstem tumor. The patient regained consciousness, with significant improvement in speech function and gradual normalization of limb move­ments.

Patient: 67-year-old male
Diagnosis: Secondary Malignant Brain Tumor
Treatment:lnitiated CyberKnife radiotherapy on August 3, 2020
Radiation dose to 95% GTV: 15 Gy in 3 fractions (5 Gy per fraction) Outcome:lmaging review three months later shows a significant reduction in the tumor size compared to previous scans.

Patient: 46-year-old female
Diagnosis: Liver Cancer
Treatment:Treatment plan involved 4D simulation positioning, with tumors in segments S2 and S3 receiv­ing a dose of so Gy ins fractions (10 Gy per fraction).
December 6, 2020: Pre-treatment MR examination showed multiple nodules in liver segments S2, S3, and S5, consistent with likely hepatocellular carcinoma. Also, a liver hemangioma in segment S6 was noted. April 14, 2021: Follow-up MR imaging indicated a significant reduction in the liver cancer lesions compared to previous scans. Additionally, there were no significant changes in the appearance of the gallbladder ad­enomyosis.